Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage
| Autor: | Grit Baier, Michael Fichter, Anette Pietrzak-Nguyen, Susanne Strand, Claudius U. Meyer, Leah Pretsch, Stephan Gehring, Katharina Landfester, Marvin Dedters, Fred Zepp |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
medicine.medical_treatment
Monophosphoryl Lipid A Nanocapsules Flow cytometry Hydroxyethyl Starch Derivatives Immune system Antigen Adjuvants Immunologic Interferon medicine Humans Cells Cultured Microscopy Confocal General Veterinary General Immunology and Microbiology medicine.diagnostic_test Chemistry Public Health Environmental and Occupational Health Dendritic Cells Th1 Cells Interleukin-12 Cell biology Toll-Like Receptor 4 Infectious Diseases Lipid A Nanomedicine Biochemistry Molecular Medicine Adjuvant CD80 medicine.drug |
| Zdroj: | Vaccine. 33(7) |
| ISSN: | 1873-2518 |
| Popis: | Enhancing delivery of antigens to dendritic cells (DCs) is essential for the induction of vigorous antigen-specific cellular immune responses. Aim of the present study was to evaluate the properties of hydroxyethyl starch nanocapsules (HES-NCs) functionalized with anti-CD40, anti-DEC205, interferon-γ (IFNγ) and/or monophosphoryl lipid A (MPLA) with respect to the overall uptake, the released cytokine profile, and the influence on phenotypic maturation of human monocyte-derived DCs using flow cytometry, confocal microscopy and enzyme-linked immunosorbent assays. NC uptake by DCs was significantly enhanced by functionalizing NCs with anti-CD40 or MPLA. With respect to the cytokine profile and the maturation status, coating with MPLA evoked a strong Th1-type cytokine response and significantly increased CD80 and CD83 expression on DCs, contrasting the moderate effects of MPLA in solution. Notably, an at least 20 fold higher amount of MPLA in solution was needed compared to the dosage of MPLA attached to HES-NCs in order to induce comparable effects, evidencing the intense dose-sparing potential of particle-bound MPLA. Reducing the amount of the vaccine adjuvant MPLA, while maintaining or even surpassing the effects on human DCs, reveals the potential of HES-NCs as a promising carrier system for the simultaneous delivery of antigen along with compounds promoting a Th1-prone cellular immune response. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect